This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Earnings Season Could Be Great for Darling Ingredients (DAR)
by Zacks Equity Research
Darling Ingredients (DAR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Post Holdings (POST) Q3 Earnings Miss Estimates, Sales Up Y/Y
by Zacks Equity Research
Post Holdings (POST) third-quarter performance reflects gains from acquisitions, recovery in foodservice channel as well as strong brand performance across certain categories.
B&G Foods (BGS) Q2 Earnings Miss Estimates, Sales Down Y/Y
by Zacks Equity Research
B&G Foods (BGS) second-quarter fiscal 2021 results reflect lower earnings and sales on unfavorable year-over-year comparisons. Also, input cost inflation affected quarterly results.
How Investors Can Grab Better Returns for Consumer Staples Using the Zacks ESP Screener
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
International Flavors (IFF) Q2 Earnings Miss Estimates, Up Y/Y
by Zacks Equity Research
International Flavors' (IFF) Q2 top-line results reflect benefits from solid growth in Scent and Nourish as well as additional sales related to the merger with DuPont's Nutrition & Biosciences (N&B) business.
3 Reasons Why Growth Investors Shouldn't Overlook Darling (DAR)
by Zacks Equity Research
Darling (DAR) possesses solid growth attributes, which could help it handily outperform the market.
Nu Skin (NUS) Q2 Earnings Beat Estimates, Sales Grow Y/Y
by Zacks Equity Research
Nu Skin's (NUS) second-quarter 2021 earnings and revenues increase year over year on growth in sales leaders. Also, management raises 2021 earnings view.
Sysco (SYY) to Post Q4 Earnings: What Awaits the Stock?
by Zacks Equity Research
Sysco's (SYY) fourth-quarter performance is likely to have gained from recovery in foodservice demand.
Medifast (MED) Surpasses Q2 Earnings & Revenue Estimates
by Zacks Equity Research
Strength in independent OPTAVIA Coaches along with gross margin expansion and lower SG&A expense rate aids Medifast (MED) in Q2.
Kellogg's (K) Q2 Earnings Top Estimates, Organic Sales View Up
by Zacks Equity Research
Kellogg's (K) second-quarter 2021 results reflect tough comparisons with the year-ago period, though away-from-home channel recovery and emerging market strength were upsides.
Darling Ingredients (DAR) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Darling Ingredients (DAR) closed the most recent trading day at $68.54, moving -1.3% from the previous trading session.
Kraft Heinz (KHC) Q2 Earnings Beat Estimates, Sales Down Y/Y
by Zacks Equity Research
Kraft Heinz's (KHC) second-quarter 2021 sales and earnings decline year over year on softness across United States business.
Tyson Foods (TSN) to Post Q3 Earnings: What Awaits the Stock?
by Zacks Equity Research
Tyson Foods' (TSN) third-quarter performance is likely to have gained from strong retail sales and recovery in foodservice demand.
What's in the Offing for International Flavors' (IFF) Q2 Earnings?
by Zacks Equity Research
International Flavors' (IFF) Q2 results likely to reflect benefits from robust demand for home care and personal categories as well as cost-reduction efforts.
Monster Beverage (MNST) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Strength in the energy drinks business, innovation and improved e-commerce are expected to have aided Monster Beverage (MNST) in Q2. Higher operating costs are likely to have dented its performance.
TreeHouse Foods (THS) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
TreeHouse Foods' (THS) second-quarter results are likely to reflect the impact of lower retail demand owing to tough comparisons with the year-ago period's stock-hoarding trends.
Beyond Meat (BYND) to Post Q2 Earnings: What Awaits the Stock?
by Zacks Equity Research
Beyond Meat's (BYND) second-quarter performance is likely to have gained from strong retail sales and recovery in foodservice demand. Rising transportation and warehouse costs are a concern.
Church & Dwight (CHD) Cuts View Despite Q2 Earnings & Sales Beat
by Zacks Equity Research
Church & Dwight's (CHD) second-quarter 2021 results benefit from strong product demand. Management lowers view due to supply-chain woes and cost inflation.
Darling Ingredients (DAR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Darling Ingredients (DAR) closed the most recent trading day at $69.51, moving -0.3% from the previous trading session.
Service Corporation's (SCI) Q2 Earnings Top Estimates, View Raised
by Zacks Equity Research
Service Corporation's (SCI) second-quarter 2021 results reflect solid earnings and sales, on strength in comparable preneed cemetery sales production and comparable preneed funeral sales production.
Hershey's (HSY) Q2 Earnings Surpass Estimates, Sales Up Y/Y
by Zacks Equity Research
Hershey's (HSY) second-quarter 2021 results reflect higher sales and earnings on strength across North America as well as International and Other unit. Management raises 2021 net sales view.
Altria (MO) Q2 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Altria's (MO) second-quarter performance reflects gains from growth in revenues across all categories, backed by favorable pricing variance and shipment volumes.
Pilgrim's Pride (PPC) Q2 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
Pilgrim's Pride's (PPC) second-quarter 2021 results reflect higher sales and earnings on strength across Mexico, the U.K. and Europe as well as the U.S. operations.
Darling Ingredients (DAR) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Darling (DAR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mondelez (MDLZ) Q2 Earnings Match Estimates, Revenues Beat
by Vrishali Bagree
Mondelez International's (MDLZ) second-quarter 2021 results reflect a rise in earnings and sales. A solid first-half performance led to a raised organic revenue growth view, though high costs are a concern.